File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Prosthetic valve endocarditis in a multicenter registry of chinese patients

TitleProsthetic valve endocarditis in a multicenter registry of chinese patients
Authors
Issue Date2010
PublisherSage Publications Ltd.. The Journal's web site is located at http://www.sagepub.com/journalsProdDesc.nav?prodId=Journal201946
Citation
Asian Cardiovascular And Thoracic Annals, 2010, v. 18 n. 5, p. 430-434 How to Cite?
AbstractWe evaluated the clinical outcomes of prosthetic valve endocarditis in 2 major tertiary referral centers in Hong Kong. The study population comprised 80 consecutive Chinese patients who fulfilled the modified Duke criteria for prosthetic valve endocarditis from March 2000 to June 2007. The major clinical endpoints analyzed were hospital mortality, need for valve surgery, and relapse of prosthetic endocarditis. The mean age at presentation was 56 ± 13 years, with a slight male preponderance. There were 76 (95%) patients with involvement of a mechanical prosthesis; the majority (69%) had late prosthetic endocarditis. Major hospital complications occurred in 49 (61%) patients. The overall hospital mortality was 28% (22 patients). Thirty-four (42%) patients required valve surgery during index hospitalization, of whom 5 (15%) died due to uncontrolled sepsis. Factors associated with hospital mortality were older age at presentation, Staphylococcus aureus infection, embolic events, severe heart failure, valve surgery, and any major complication. On multivariate analysis, severe heart failure was the only independent predictor of hospital death. Among the 58 hospital survivors followed up for a mean of 48 ± 31 months, 6 (10%) developed late complications related to prosthetic valve endocarditis, with 5 documented cases of relapse. © SAGE Publications 2010.
Persistent Identifierhttp://hdl.handle.net/10722/134126
ISSN
2015 SCImago Journal Rankings: 0.264
References

 

DC FieldValueLanguage
dc.contributor.authorHo, HHen_HK
dc.contributor.authorSiu, CWen_HK
dc.contributor.authorYiu, KHen_HK
dc.contributor.authorTse, HFen_HK
dc.contributor.authorChui, WHen_HK
dc.contributor.authorChow, WHen_HK
dc.date.accessioned2011-06-13T07:19:53Z-
dc.date.available2011-06-13T07:19:53Z-
dc.date.issued2010en_HK
dc.identifier.citationAsian Cardiovascular And Thoracic Annals, 2010, v. 18 n. 5, p. 430-434en_HK
dc.identifier.issn0218-4923en_HK
dc.identifier.urihttp://hdl.handle.net/10722/134126-
dc.description.abstractWe evaluated the clinical outcomes of prosthetic valve endocarditis in 2 major tertiary referral centers in Hong Kong. The study population comprised 80 consecutive Chinese patients who fulfilled the modified Duke criteria for prosthetic valve endocarditis from March 2000 to June 2007. The major clinical endpoints analyzed were hospital mortality, need for valve surgery, and relapse of prosthetic endocarditis. The mean age at presentation was 56 ± 13 years, with a slight male preponderance. There were 76 (95%) patients with involvement of a mechanical prosthesis; the majority (69%) had late prosthetic endocarditis. Major hospital complications occurred in 49 (61%) patients. The overall hospital mortality was 28% (22 patients). Thirty-four (42%) patients required valve surgery during index hospitalization, of whom 5 (15%) died due to uncontrolled sepsis. Factors associated with hospital mortality were older age at presentation, Staphylococcus aureus infection, embolic events, severe heart failure, valve surgery, and any major complication. On multivariate analysis, severe heart failure was the only independent predictor of hospital death. Among the 58 hospital survivors followed up for a mean of 48 ± 31 months, 6 (10%) developed late complications related to prosthetic valve endocarditis, with 5 documented cases of relapse. © SAGE Publications 2010.en_HK
dc.languageengen_US
dc.publisherSage Publications Ltd.. The Journal's web site is located at http://www.sagepub.com/journalsProdDesc.nav?prodId=Journal201946en_HK
dc.relation.ispartofAsian Cardiovascular and Thoracic Annalsen_HK
dc.subject.meshAdulten_HK
dc.subject.meshAgeden_HK
dc.subject.meshChinaen_HK
dc.subject.meshEndocarditis, Bacterial - etiology - mortality - surgeryen_HK
dc.subject.meshFemaleen_HK
dc.subject.meshHeart Valve Prosthesis - adverse effectsen_HK
dc.subject.meshHeart Valve Prosthesis Implantation - adverse effects - instrumentationen_HK
dc.subject.meshHospital Mortalityen_HK
dc.subject.meshHumansen_HK
dc.subject.meshMaleen_HK
dc.subject.meshMiddle Ageden_HK
dc.subject.meshProsthesis-Related Infections - etiology - mortality - surgeryen_HK
dc.subject.meshRecurrenceen_HK
dc.subject.meshRegistriesen_HK
dc.subject.meshReoperationen_HK
dc.subject.meshRetrospective Studiesen_HK
dc.subject.meshRisk Assessmenten_HK
dc.subject.meshRisk Factorsen_HK
dc.subject.meshSepsis - etiology - mortalityen_HK
dc.subject.meshTime Factorsen_HK
dc.subject.meshTreatment Outcomeen_HK
dc.titleProsthetic valve endocarditis in a multicenter registry of chinese patientsen_HK
dc.typeArticleen_HK
dc.identifier.emailSiu, CW:cwdsiu@hkucc.hku.hken_HK
dc.identifier.emailYiu, KH:khkyiu@hku.hken_HK
dc.identifier.emailTse, HF:hftse@hkucc.hku.hken_HK
dc.identifier.authoritySiu, CW=rp00534en_HK
dc.identifier.authorityYiu, KH=rp01490en_HK
dc.identifier.authorityTse, HF=rp00428en_HK
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1177/0218492310379457en_HK
dc.identifier.pmid20947596-
dc.identifier.scopuseid_2-s2.0-78651241263en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-78651241263&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume18en_HK
dc.identifier.issue5en_HK
dc.identifier.spage430en_HK
dc.identifier.epage434en_HK
dc.publisher.placeUnited Kingdomen_HK
dc.identifier.scopusauthoridHo, HH=35209997400en_HK
dc.identifier.scopusauthoridSiu, CW=7006550690en_HK
dc.identifier.scopusauthoridYiu, KH=35172267800en_HK
dc.identifier.scopusauthoridTse, HF=7006070805en_HK
dc.identifier.scopusauthoridChui, WH=7003524497en_HK
dc.identifier.scopusauthoridChow, WH=7402281062en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats